目次

Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
What's New in This Update?
Methodology
Information Sources
Geographic Breakdown
Segmentation Breakdown

Chapter- 2: Summary and Highlights
Market Outlook
Market Summary

Chapter- 3: Market Overview
Evolution of RNA Therapeutics
DNA Therapeutics vs. RNA Therapeutics
Clinical Need for RNA Therapeutics
RNA Therapeutics
Manufacturing RNA-Based Biopharmaceuticals
Delivery of RNA Therapeutics
Institution and Hospital-Based RNA Therapeutics
Regulatory Influence on the Market for RNA Therapeutics
Impact of COVID-19

Chapter- 4: Market Dynamics
Market Dynamics

Chapter- 5: Target Disease and Disorders
Overview of Common Diseases and Disorders for mRNA Therapeutics
Tobacco Smoking and Associated Diseases
Infectious Diseases: COVID-19 Pandemic and mRNA Therapeutics
Chronic Diseases: Expanding Horizon for mRNA Therapeutics
Unmet Needs of Rare Diseases: mRNA Therapeutics
Aging, Gender and Onset of Diseases

Chapter- 6: Pipeline and Clinical Trial Analysis
mRNA Vaccines
mRNA Therapeutics
Clinical Trial Analysis

Chapter- 7: Market Breakdown by Product
Mechanism of Action of mRNA COVID Vaccines
Three Most-Advanced mRNA Vaccines
Figure 38 : Global Market for mRNA Therapeutics, 2021-2028

Chapter- 8: Market Breakdown by Region
North America
Europe
Asia-Pacific
RoW
Table 36 : Global Market for mRNA Therapeutics, by Region, Through 2028

Chapter- 9: Emerging Technologies and Developments
Overview

Chapter- 10: Patent Analysis
Patent Analysis

Chapter- 11: Outlook for Mergers & Acquisitions, and Venture Funding
Figure 43 : Funding in the mRNA Market, by Various Sources, 2021-2023
Table 46 : Recent M&A Deals on mRNA Therapeutics Company, 2006-2021

Chapter- 12: Competitive Intelligence
Figure 44 : Top Three Companies: mRNA Vaccines and Therapeutics
Table 47 : Major Development of Company Profiles, 2021-2023
Figure 45 : Share of Key Growth Strategies of Major Companies, 2021-2023

Chapter- 13: Company Profiles
ARCTUR U.S. THERAPEUTICS INC.
BIONTECH SE
CUREVAC N.V.
GENNOVA BIOPHARMACEUTICALS LTD.
MERCK KGAA
MODERNA INC.
NUTCRACKER THERAPEUTICS
OMEGA THERAPEUTICS INC.
STRAND THERAPEUTICS
VAXESS TECHNOLOGIES INC.